Average Co-Inventor Count = 7.52
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (21 from 378 patents)
2. Bayer Aktiengesellschaft (15 from 12,165 patents)
3. Bayer Intellectual Property Gmbh (12 from 721 patents)
4. Seattle Genetics, Inc. (4 from 132 patents)
5. Bayer Akiengesellschaft (1 from 1 patent)
47 patents:
1. 12144865 - Antibody drug conjugates with enzymatically cleavable groups
2. 12059472 - Prodrugs of cytotoxic active agents having enzymatically cleavable groups
3. 11806404 - Site specific homogeneous with KSP inhibitors
4. 11685714 - Prodrugs of cytotoxic active agents having enzymatically cleavable groups
5. 11660351 - Antibody drug conjugates (ADCs) having enzymatically cleavable groups
6. 11643469 - Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies
7. 11478554 - Antibody drug conjugates (ADCS) having enzymatically cleavable groups
8. 11433140 - Specific antibody drug conjugates (ADCs) having KSP inhibitors
9. 11123439 - Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups
10. 11071788 - Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies
11. 11001636 - Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies
12. 10973923 - Site specific homogeneous with KSP inhibitors
13. 10744205 - Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodies
14. 10485880 - Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies
15. 10350206 - Benzyl substituted indazoles as BUB1 inhibitors